UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of clinical investigation, ISSN 0021-9738, 10/2014, Volume 124, Issue 10, pp. 4577 - 4589
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Sepsis - immunology | Cell Proliferation | Bone Marrow Cells - cytology | Cell Separation | Interleukin-4 - metabolism | Mice, Inbred C57BL | Male | Inflammation - immunology | Macrophages - cytology | Macrophages, Peritoneal - cytology | Microscopy, Confocal | Peritonitis - pathology | Animals | Flow Cytometry | Bacterial Infections | Mast Cells - cytology | Mice | Phagocytosis | Sepsis | Development and progression | Genetic aspects | Mast cells | Properties | Macrophages | Histamine | Bacterial infections | Statistical analysis | Infections | Mutation | Experiments | Allergies | Index Medicus | Abridged Index Medicus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 10/2010, Volume 10, Issue 1, pp. 303 - 303
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Carcinoma, Hepatocellular - epidemiology | Hepatitis C, Chronic - pathology | HIV Infections - epidemiology | Humans | Middle Aged | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Liver Neoplasms - epidemiology | HIV Infections - pathology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Surveys and Questionnaires | Hepatitis C, Chronic - epidemiology | Hepacivirus - isolation & purification | France - epidemiology | Risk Factors | CD4 Lymphocyte Count | Hepatitis C, Chronic - drug therapy | Disease Progression | Antiretroviral Therapy, Highly Active | Medication Adherence | HIV Infections - complications | HIV Infections - drug therapy | Longitudinal Studies | Cohort analysis | Usage | Demographic aspects | Comorbidity | Distribution | Reports | Hepatitis C | HIV infection | Antiretroviral drugs | Liver diseases | Disease | Physicians | Mortality | Hepatitis | Liver cancer | Hospitals | Human immunodeficiency virus--HIV | Data collection | Behavior | Clinical medicine | Liver cirrhosis | Index Medicus | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1022 - 1039
Life Sciences & Biomedicine | Oncology | Science & Technology | Rare Diseases - mortality | Humans | Europe - epidemiology | Hospitalization - statistics & numerical data | Neoplasms - mortality | Rare Diseases - epidemiology | Male | Survival Rate | Cancer Care Facilities | Incidence | Neoplasms - therapy | Rare Diseases - therapy | Delivery of Health Care | Female | Registries | Neoplasms - epidemiology | Index Medicus | Life Sciences
Journal Article
Journal of internal medicine, ISSN 0954-6820, 04/2014, Volume 275, Issue 4, pp. 398 - 408
vaccine safety | autoimmune disorders | human papillomavirus vaccine | systematic case–control study | human papillomavirus | vaccination | Vaccine safety | Human papillomavirus | Systematic case-control study | Human papillomavirus vaccine | Autoimmune disorders | Vaccination | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Autoimmune Diseases - epidemiology | France - epidemiology | Humans | Mass Vaccination - statistics & numerical data | Risk Factors | Autoimmune Diseases - immunology | Autoimmune Diseases - etiology | Case-Control Studies | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Incidence | Alphapapillomavirus | Young Adult | Connective Tissue Diseases - immunology | Papillomavirus Infections - prevention & control | Purpura, Thrombocytopenic, Idiopathic - immunology | Adolescent | Multiple Sclerosis - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - adverse effects | Adult | Female | Diabetes Mellitus, Type 1 - immunology | Papillomavirus Vaccines - administration & dosage | Papillomaviruses | AIDS vaccines | Guillain-Barre syndrome | Type 1 diabetes | Analysis | Oral contraceptives | Index Medicus | Life Sciences
Journal Article
Nature (London), ISSN 0028-0836, 04/2008, Volume 452, Issue 7187, pp. 633 - 637
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - genetics | Genetic Predisposition to Disease - genetics | Europe | Humans | Polymorphism, Single Nucleotide - genetics | Genotype | Chromosomes, Human, Pair 15 - genetics | Odds Ratio | Receptors, Nicotinic - genetics | Protein Subunits - genetics | Lung cancer | Genomics | Risk factors | Nicotine | Smoking | Index Medicus | Life Sciences | Cancer
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2016, Volume 152, Issue 1, pp. 142 - 156.e2
Gastroenterology and Hepatology | ANRS CirVir | Prognosis | Direct Antivirals | HCV Clearance | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Carcinoma, Hepatocellular - epidemiology | Carcinoma, Hepatocellular - mortality | Prospective Studies | Follow-Up Studies | Hepatitis C - drug therapy | gamma-Glutamyltransferase - blood | Humans | Middle Aged | Prothrombin Time | Liver Cirrhosis - mortality | Male | Liver Neoplasms - mortality | Incidence | Liver Neoplasms - epidemiology | Cardiovascular Diseases - epidemiology | Female | Hepatitis C - complications | Metabolic Syndrome - epidemiology | Body Mass Index | France - epidemiology | Antiviral Agents - therapeutic use | Liver Cirrhosis - complications | Dyslipidemias - epidemiology | Platelet Count | Aspartate Aminotransferases - blood | Diabetes Mellitus - epidemiology | Hepatitis C - mortality | Bacterial Infections - epidemiology | Aged | Liver Cirrhosis - physiopathology | Sustained Virologic Response | Virus diseases | Care and treatment | Control | Liver | Hepatitis C virus | Health aspects | Liver cirrhosis | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Cancer
Journal Article
Journal of hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 6, pp. 1114 - 1122
Gastroenterology and Hepatology | Antiviral | Resistant variants | Hepatitis C virus | Pegylated interferon | Ribavirin | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Antiviral agents | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Male | Thiazoles - administration & dosage | Recombinant Proteins | Oligopeptides - adverse effects | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Protease Inhibitors - pharmacology | Hepatitis C - blood | Ribavirin - administration & dosage | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Double-Blind Method | Oligopeptides - pharmacokinetics | Carrier Proteins - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins | Viral Nonstructural Proteins - genetics | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Drug Resistance, Viral - genetics | Hepacivirus - enzymology | Antiviral Agents - adverse effects | Hepatitis C - virology | Interferon alpha-2 | Oligopeptides - administration & dosage | Thiazoles - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Care and treatment | Safety and security measures | Hotels and motels | Immunodeficiency | Aspartate | Biological response modifiers | HIV (Viruses) | Anti-HIV agents | Complications and side effects | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C | Index Medicus | Viral Nonstructural Proteins | Oligopeptides | Polyethylene Glycols | Interferon-alpha | Protease Inhibitors | Drug Resistance, Viral | Antiviral Agents | Viral Load | Life Sciences | Thiazoles | Hepacivirus | Carrier Proteins | Cancer
Journal Article
Gut, ISSN 0017-5749, 02/2017, Volume 66, Issue 2, pp. 330 - 341
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Failure - mortality | Prognosis | Prospective Studies | Urinary Tract Infections - mortality | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Hepatitis C, Chronic - complications | Liver Neoplasms - mortality | Cause of Death | Incidence | Peritonitis - microbiology | Pneumonia - mortality | Adult | Female | Severity of Illness Index | France - epidemiology | Risk Factors | Survival Rate | Peritonitis - mortality | Hepatitis B, Chronic - complications | Liver Cirrhosis - virology | Liver Cirrhosis - physiopathology | Bacterial Infections - mortality | Coinfection - mortality | Bacterial infections | Diagnosis | Liver cirrhosis | Index Medicus | Abridged Index Medicus | Life Sciences | Microbiology and Parasitology
Journal Article